Language – Page 2

BIOSECURE Act Clears House Hurdle, Heads to Senate for Vote on Restricting Chinese Biotech Ties

8 months ago talkbio0Tagged BIOSECURE, Biotech Companies, Biotechnology, Chinese Language, Drug Industry, drug supply chain, innovation, National Security, Risk, Senate, United States, US House of Representatives, Voting

BIOSECURE Act, House of Representatives, Senate Vote, Chinese Biotech Companies, National Security Risks, U.S. Pharmaceutical Industry, Biotechnology Innovation, Drug Supply Chain

GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy with Less Weight Gain in HIV Trial

9 months ago talkbio0Tagged Biktarvy, DOBLE, Dovato, Gilead, HIV, PASO, SmithKline Beecham, Spanish, Spanish Language, ViiV Healthcare

GSK, Dovato, Gilead, Biktarvy, HIV, weight gain, Spanish trial, PASO DOBLE, ViiV Healthcare

US Speaker Promises Vote on BIOSECURE Act to Halt Federal Contracts with Chinese Biotech Companies

10 months ago talkbio0Tagged BIOSECURE, Chinese Language, Contract agreement, federal, Health care facility, House Speaker Mike Johnson, National Security

BIOSECURE Act, House Speaker Mike Johnson, Chinese biotech companies, federal contracts, healthcare data, national security

SciRhom Secures €63 Million in Series A Funding for Autoimmune Therapies

10 months ago talkbio0Tagged Autoimmune Diseases, Funding, RHBDF2 gene, SciRhom, Series, therapeutic strategy

SciRhom, autoimmune diseases, iRhom2, therapeutic strategy, Series A funding, biotech, pharmaceuticals

Grifols Founding Family and Brookfield Plan to Take Drugmaker Private

10 months ago talkbio0Tagged Brookfield, drugmaker, Grifols, Nasdaq, Private Equity, Spanish Language, Stock exchange, Takeover Bid

Grifols, Brookfield, Private Equity, Takeover Bid, Spanish Drugmaker, Nasdaq, Spanish Stock Exchange

Western In-Licensing Deals with Chinese Companies: Focus on Disease Areas and Drug Types

11 months ago talkbio0Tagged Biopharma, Chinese Language, cross-border partnerships, in-licensing, Licensing trends, pharmaceutical companies, Type of drug, West (direction)

, In-licensing deals, Chinese pharmaceutical companies, Western pharmaceutical companies, Disease areas, Drug types, Cross-border partnerships, Biopharma, Licensing trends,

Italian Antitrust Agency Investigates Novartis, Biogen, and Others Over Lucentis Biosimilar

11 months ago talkbio0Tagged Antitrust Probe, Authority, Bioepis, Biogen, Biosimilars, Byooviz, competition, genentech, Italian language, Lucentis, Novartis, Samsung

Italian Competition Authority, Novartis, Biogen, Samsung Bioepis, Genentech, Lucentis, Byooviz, Biosimilar, Antitrust Probe

Eisai and Biogen Overcome Filing Hitch, Initiate FDA Submission for Subcutaneous Leqembi

11 months ago talkbio0Tagged Alzheimer 's disease, Amyloid beta-Peptides, Biogen, Blackfoot language, Clinical Trials, Eisai, Leqembi, Monoclonal Antibodies, rolling, subcutaneous, Submission, United States Food and Drug Administration

Eisai, Biogen, FDA submission, Leqembi, subcutaneous, Alzheimer’s disease, rolling submission, BLA, clinical trials, monoclonal antibody, amyloid beta, neurodegenerative disorder